29% Of U.S. Opioid Treatment Programs Owned By Private Equity Firms

About 29% of the 1,932 opioid treatment programs (OTPs) in the United States are owned by private equity firms, totaling 562 OTPs. In other health care sectors, private equity ownership ranges from 2% to 11% of organizations in the sector.

The 562 OTPs owned by private equity belonged to one of 11 parent companies. The three largest parent companies accounted for 54.6% (307 OTPs) owned by private equity. The names of these three firms were not offered in the study.

In 14 states, over half of OTPs were owned by private equity. In three states (Montana, Nebraska, and . . .